153 related articles for article (PubMed ID: 10973631)
1. FK506 suppresses neutrophil chemoattractant production by peripheral blood mononuclear cells.
Sasakawa Y; Sakuma S; Higashi Y; Sasakawa T; Amaya T; Goto T
Eur J Pharmacol; 2000 Sep; 403(3):281-8. PubMed ID: 10973631
[TBL] [Abstract][Full Text] [Related]
2. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
[TBL] [Abstract][Full Text] [Related]
3. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
[TBL] [Abstract][Full Text] [Related]
4. FK506 inhibits prostaglandin E2 production from synovial cells by suppressing peripheral blood mononuclear cells.
Sasakawa T; Sasakawa Y; Ohkubo Y; Mutoh S
Int Immunopharmacol; 2005 Jul; 5(7-8):1291-7. PubMed ID: 15914333
[TBL] [Abstract][Full Text] [Related]
5. FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthma.
Sano T; Nakamura Y; Matsunaga Y; Takahashi T; Azuma M; Okano Y; Shimizu E; Ogushi F; Sone S; Ogura T
Eur Respir J; 1995 Sep; 8(9):1473-8. PubMed ID: 8575571
[TBL] [Abstract][Full Text] [Related]
6. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
Schleimer RP; Freeland HS; Peters SP; Brown KE; Derse CP
J Pharmacol Exp Ther; 1989 Aug; 250(2):598-605. PubMed ID: 2547940
[TBL] [Abstract][Full Text] [Related]
7. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
8. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
Harvath L; Aksamit RR
J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
Harvath L; Yancey KB; Katz SI
J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
[TBL] [Abstract][Full Text] [Related]
10. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
[TBL] [Abstract][Full Text] [Related]
11. FK506 suppresses E-selectin, ICAM-1 and VCAM-1 expression on vascular endothelial cells by inhibiting tumor necrosis factor alpha secretion from peripheral blood mononuclear cells.
Sasakawa T; Sasakawa Y; Masunaga T; Fujitsu T; Hirayama Y; Ohkubo Y; Mutoh S
Cytokine; 2005 Jan; 29(2):67-71. PubMed ID: 15598440
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).
Yoshimura T; Matsushima K; Oppenheim JJ; Leonard EJ
J Immunol; 1987 Aug; 139(3):788-93. PubMed ID: 3298433
[TBL] [Abstract][Full Text] [Related]
13. Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox control.
Furuke K; Nakamura H; Hori T; Iwata S; Maekawa N; Inamoto T; Yamaoka Y; Yodoi J
Int Immunol; 1995 Jun; 7(6):985-93. PubMed ID: 7577807
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte chemotactic activity of FKBP and inhibition by FK506.
Leiva MC; Lyttle CR
Biochem Biophys Res Commun; 1992 Jul; 186(2):1178-83. PubMed ID: 1379802
[TBL] [Abstract][Full Text] [Related]
15. Modulation of interleukin-1 secretion by immunosuppressive drugs, alone and in combination.
Reisman L; Lin WG; Martinelli GP
Transpl Immunol; 1995 Mar; 3(1):45-9. PubMed ID: 7551978
[TBL] [Abstract][Full Text] [Related]
16. Formyl peptide receptor 1 and 2 dual agonist inhibits human neutrophil chemotaxis by the induction of chemoattractant receptor cross-desensitization.
Sogawa Y; Ohyama T; Maeda H; Hirahara K
J Pharmacol Sci; 2011; 115(1):63-8. PubMed ID: 21173551
[TBL] [Abstract][Full Text] [Related]
17. Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro.
Vicioso MA; Garaud JJ; Réglier-Poupet H; Lebeaut A; Gougerot-Pocidalo MA; Chollet-Martin S
Eur Cytokine Netw; 1998 Sep; 9(3):247-53. PubMed ID: 9831173
[TBL] [Abstract][Full Text] [Related]
18. Effect of immunosuppressive regimens on neutrophil chemotaxis.
Di Stefano R; Scavuzzo M; Pietrabissa A; Donati D; Carmellini M; Rizzo G; Rindi P; Mosca F
Transplant Proc; 1994 Oct; 26(5):2861-2. PubMed ID: 7940901
[No Abstract] [Full Text] [Related]
19. Endotoxin promotes neutrophil hierarchical chemotaxis via the p38-membrane receptor pathway.
Wang X; Qin W; Zhang Y; Zhang H; Sun B
Oncotarget; 2016 Nov; 7(45):74247-74258. PubMed ID: 27655676
[TBL] [Abstract][Full Text] [Related]
20. Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid.
Mori A; Suko M; Nishizaki Y; Kaminuma O; Matsuzaki G; Ito K; Etoh T; Nakagawa H; Tsuruoka N; Okudaira H
Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):32-5. PubMed ID: 7512393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
